Molecular imaging of adrenal neoplasms

被引：15

作者：

Chen, Clara C. ^{[3
]}

Carrasquillo, Jorge A. ^{[1
,2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, Mol Imaging & Therapy Serv, New York, NY 10021 USA

[2] Weill Cornell Med Ctr, Dept Radiol, New York, NY USA

[3] NIH, Div Nucl Med, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2012年 / 106卷 / 05期

关键词：

MIBG; somatostatin; FDG; fluorodopa; pheochromocytoma; neuroblastoma; POSITRON-EMISSION-TOMOGRAPHY; HIGH-RISK NEUROBLASTOMA; I-123 METAIODOBENZYLGUANIDINE SCINTIGRAPHY; 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE; PROSPECTIVE MULTICENTER TRIAL; INRG TASK-FORCE; FOLLOW-UP; F-18-FDG PET/CT; ADRENOCORTICAL CARCINOMA; SOMATOSTATIN RECEPTORS;

D O I：

10.1002/jso.23162

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The adrenal glands are complex structures from which a variety of benign and malignant tumors may arise and are a common site of metastatic disease. Several radiopharmaceuticals are used for imaging the adrenals, including I-123/I-131 metaiodobenzylguanidine (MIBG), norcholesterol derivatives, In-111 pentetreotide and Ga-68 somatostatin analogs, [F-18]fluorodeoxyglucose, [F-18]fluorodopa, [F-18]fluorodopamine, C-11 meta hydroxyephedrine, and C-11/F-18/I-123 Metomidate (MTO) or its analogs. In this review we focus on the role of these reagents in metastatic lesions, cortical neoplasms, pheochromocytoma/paraganglioma, and neuroblastoma (NB). J. Surg. Oncol. 2012; 106:532542. (C) 2012 Wiley Periodicals, Inc.

引用

页码：532 / 542

页数：11

共 112 条

[21] METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) LABELED WITH I-123/I-131 IN NEUROBLASTOMA DIAGNOSIS AND FOLLOW-UP TREATMENT WITH A REVIEW OF THE DIAGNOSTIC RESULTS OF THE INTERNATIONAL WORKSHOP OF PEDIATRIC ONCOLOGY HELD IN ROME, SEPTEMBER 1986 [J].

FEINE, U ;

MULLERSCHAUENBURG, W ;

TREUNER, J ;

KLINGEBIEL, T .

MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (04) :181-187

[22] 6-[F-18]Fluoro-L-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess [J].

Fiebrich, Helle-Brit ;

Brouwers, Adrienne H. ;

Kerstens, Michiel N. ;

Pijl, Milan E. J. ;

Kema, Ido P. ;

de Jong, Johan R. ;

Jager, Pieter L. ;

Elsinga, Philip H. ;

Dierckx, Rudi A. J. O. ;

van der Wal, Jacqueline E. ;

Sluiter, Wim J. ;

de Vries, Elisabeth G. E. ;

Links, Thera P. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10) :3922-3930

[23] ADRENAL LOCALIZATION IN THE ADRENOCORTICOTROPIC HORMONE-INDEPENDENT CUSHING SYNDROME [J].

FIG, LM ;

GROSS, MD ;

SHAPIRO, B ;

EHRMANN, DA ;

FREITAS, JE ;

SCHTEINGART, DE ;

GLAZER, GM ;

FRANCIS, IR .

ANNALS OF INTERNAL MEDICINE, 1988, 109 (07) :547-553

[24] 6-18F-Fluoro-L-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to 123I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extraadrenal and Hereditary Pheochromocytomas and Paragangliomas: with Vesicular Monoamine Transporter Expression [J].

Fottner, C. ;

Helisch, A. ;

Anlauf, M. ;

Rossmann, H. ;

Musholt, T. J. ;

Kreft, A. ;

Schadmand-Fischer, S. ;

Bartenstein, P. ;

Lackner, K. J. ;

Kloeppel, G. ;

Schreckenberger, M. ;

Weber, M. M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06) :2800-2810

[25]

Franzius C, 2006, J NUCL MED, V47, P1635

[26] Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy [J].

Furuta, N ;

Kiyota, H ;

Yoshigoe, F ;

Hasegawa, N ;

Ohishi, Y .

INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (03) :119-124

[27] Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma [J].

Gimenez-Roqueplo, AP ;

Favier, J ;

Rustin, P ;

Rieubland, C ;

Kerlan, V ;

Plouin, PF ;

Rötig, A ;

Jeunemaitre, X .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4771-4774

[28]

GORDON I, 1990, J NUCL MED, V31, P129

[29] Incidental Non-secreting Adrenal Masses in Cancer Patients: Intra-individual Comparison of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography with Computed Tomography and Shift Magnetic Resonance Imaging [J].

Gratz, S. ;

Kemke, B. ;

Kaiser, W. ;

Heinis, J. ;

Behr, T. M. ;

Hoeffken, H. .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (02) :633-644

[30]

Gross MD, 2009, MINERVA ENDOCRINOL, V34, P171

← 1 2 3 4 5 6 7 8 9 10 →